Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

136.43
Delayed Data
As of Jun 23
 +0.38 / +0.28%
Today’s Change
109.32
Today|||52-Week Range
137.00
+18.42%
Year-to-Date
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonob...
Jun 23 / Zacks.com - Paid Partner Content
Company News for June 19, 2017
Jun 19 / Zacks.com - Paid Partner Content
Healthcare ETF (IYH) Hits New 52-Week High
Jun 23 / Zacks.com - Paid Partner Content
These 7 Companies Are Finding Strength In a Weak Dollar, Jim Cramer Explains
Jun 19 / TheStreet.com - Paid Partner Content
Samsung Could Sell More Drugs
Jun 23 / TheStreet.com - Paid Partner Content
J&J Immunotherapy Darzalex Ok'd for Expanded Combination Use
Jun 19 / Zacks.com - Paid Partner Content
Trump names Woody Johnson as UK ambassador
Jun 23 / FT.com - Paid Partner Content
Procter & Gamble Could Be Nearing a Bruising Battle With This Legendary Activist Inve...
Jun 19 / TheStreet.com - Paid Partner Content
Executive choice: to build or buy the next leader?
Jun 22 / FT.com - Paid Partner Content
Actelion spin-off Idorsia up 30% on market debut
Jun 16 / FT.com - Paid Partner Content
Here's Why Geron (GERN) is a Good Stock to Invest in Now
Jun 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused
Jun 16 / Zacks.com - Paid Partner Content
Cramer: This Is No Country for Old Value
Jun 21 / TheStreet.com - Paid Partner Content
Alphabet life sciences arm to invest in EU drug development
Jun 14 / FT.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
J&J's Invokana Lowers Heart Issues, Raises Amputation Risk
Jun 13 / Zacks.com - Paid Partner Content
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
Jun 21 / TheStreet.com - Paid Partner Content
Amgen's Multiple Myeloma Drug Receives NICE Recommendation
Jun 13 / Zacks.com - Paid Partner Content
Fitch Sees Fastest Global Growth in 10 Years: ETFs To Buy
Jun 21 / Zacks.com - Paid Partner Content
J&J Announces EU Regulatory Approval for Actelion Deal
Jun 12 / Zacks.com - Paid Partner Content
Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US
Jun 21 / Zacks.com - Paid Partner Content
Big US pharma dealmaking plunges to five-year low
Jun 12 / FT.com - Paid Partner Content
Zacks.com featured highlights: Johnson & Johnson, NantKwest, Delek US Holdings, Abbot...
Jun 21 / Zacks.com - Paid Partner Content
Google loses more advertisers over hate videos
Jun 07 / CNNMoney.com
Major Talc Case Against J&J Declared a Mistrial Following SCOTUS Ruling
Jun 21 / TheStreet.com - Paid Partner Content
PPG-Akzo: cold war
Jun 01 / FT.com - Paid Partner Content
J&J-AbbVie's Imbruvica Positive in Follow-up Lymphoma Study
Jun 20 / Zacks.com - Paid Partner Content
Ohio blames drugmakers for fueling opioid crisis
Jun 01 / CNNMoney.com
Big Oil wants to tax itself and give cash to Americans
Jun 20 / CNNMoney.com
Ohio sues drugmakers over US opioid addiction crisis
May 31 / FT.com - Paid Partner Content
Leading corporations support US carbon tax campaign
Jun 20 / FT.com - Paid Partner Content
Big business wants Trump to stick with Paris climate accord
May 29 / CNNMoney.com
AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?
Jun 19 / Zacks.com - Paid Partner Content